About Delta Biopharma Private Limited
Data last updated:
Delta Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2012PTC238604. Its GSTIN is 27AAECD7792H1Z8 (Maharashtra). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹50.2 Cr and a paid-up capital of ₹50 Cr. It is led by directors including Rajiv Khanna and Chander Mohan Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1017/1018 Corporate Avenue Sonawala Road Goregaon East, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2025, the company reported a revenue of ₹65.22 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹4.51 Cr (net margin -6.9%) and EBITDA of ₹3.95 Cr (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 24% over five years.
The company has about 175 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹2.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zifampinnacle.com.
Company details
Contact details
Delta Biopharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is zifampinnacle.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1017/1018 Corporate Avenue Sonawala Road Goregaon East, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Delta Biopharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Delta Biopharma are trade, professional, scientific and technical and manufacturing. In detail, this covers wholesale trading, other professional, scientific and technical activities and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Delta Biopharma Private Limited, buy the company report.
Financials of Delta Biopharma Private Limited
FY 2025 filings availableDelta Biopharma Private Limited reported revenue of ₹65.22 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 20% growth in the latest year. EBITDA rose 270% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.51 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | ||||
| Net Profit Margin | -6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Delta Biopharma Private Limited, buy the company report.
Board of directors of Delta Biopharma Private Limited
Delta Biopharma has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Khanna | Director | 31 Mar 2015 | 11 Years 6 Months | Current |
| Chander Mohan Khanna | Director | 08 Dec 2012 | 13 Years 10 Months | Current |
| Rita Khanna | Director | 08 Dec 2012 | 13 Years 10 Months | Current |
| Rajat Chander Mohan Khanna | Director | 08 Dec 2012 | 13 Years 10 Months | Current |
Auditor
Delta Biopharma Private Limited is audited by R K Khanna & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R K Khanna & Co. | FY 2024 | 000033N |
Shareholding
The shareholding of Delta Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Delta Biopharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2022 | 100553489 | Axis Bank Limited | ₹2.7 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Delta Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Delta Biopharma Private Limited has 5 MSME Form 1 returns on record between 2018 and 2024, listing 38 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| All India Warehousing Private Limited | |||
| Paramount Art Prints Private Limited | |||
| Empirical Aromatics LLP | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Delta Biopharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Delta Biopharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Zifam Pinnacle Healthcare Private Limited | U24100MH2010PTC198697 |
To see the full group structure of Delta Biopharma Private Limited, buy the company report.
Employees & EPFO
Delta Biopharma Private Limited has a workforce of 175 employees on its EPFO records as of Sep 22, 2025, across 1 active EPFO establishment.
GST
Delta Biopharma has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECD7792H1Z8 | Maharashtra | Active | 01 Jul 2017 |
| 27AAECD7792H2Z7 | Maharashtra | Active | 01 Apr 2025 |
| 33AAECD7792H1ZF | Tamil Nadu | Active | 01 Jul 2017 |
| 37AAECD7792H1Z7 | Andhra Pradesh | Active | 09 Feb 2018 |
To see the full GST registrations and return filing status of Delta Biopharma Private Limited, buy the company report.
Recent activity
Delta Biopharma Private Limited has 7 board changes on record since 2012: 4 appointments and 3 cessations. The latest: Jyoti Rani ceased to be Company Secretary on 01 Aug 2025.
Frequently asked questions
Delta Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 December 2012 (14+ years old) and is registered under CIN U24100MH2012PTC238604.
Delta Biopharma has 4 current directors:
- Rajiv Khanna - Director
- Chander Mohan Khanna - Director
- Rita Khanna - Director
- Rajat Chander Mohan Khanna - Director
The latest financial statements of Delta Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Delta Biopharma is 27AAECD7792H1Z8, registered in Maharashtra. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AAECD7792H2Z7 (Maharashtra), 33AAECD7792H1ZF (Tamil Nadu), 37AAECD7792H1Z7 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Delta Biopharma is U24100MH2012PTC238604. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delta Biopharma was incorporated on 08 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Jyoti Rani ceased to be Company Secretary on 01 Aug 2025. Rakesh Kumar Sinha ceased to be Additional Director on 20 Dec 2022. Rajiv Khanna ceased to be Additional Director on 30 Sep 2015. Delta Biopharma has 7 board changes on record in total.
Delta Biopharma has 5 MSME Form 1 returns on record between 2018 and 2024, listing 38 overdue payments to 34 micro and small suppliers. The latest return was filed on 01 May 2024.
Delta Biopharma can be reached through the website zifampinnacle.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Delta Biopharma is at 10171018 Corporate Avenue Sonawala Road Goregaon East, Mumbai, Maharashtra, India – 400063.
Delta Biopharma operates in the pharma industry, in the drug formulation and development segment.